title: Reduced expression of macrophage-associated antigens on alveolar mononuclear phagocytes from acquired immunodeficiency syndrome.
abstract: In this study we evaluated the phenotype of alveolar mononuclear phagocytes recovered from the bronchoalveolar lavage fluid of 24 patients with human immunodeficiency virus infection (AIDS-related complex 8 patients. AIDS 16 patients) and 8 healthy individuals by using a panel of monoclonal antibodies known to react with tissue macrophages, in combination with a flow cytometer. The results showed that 90% of patients with AIDS present a marked reduction in the expression of several antigenic determinants (in decreasing order: CD68, CD36, CR1, CD11c, HLA-DR). The levels of antigen expression by flow cytometry seem to decline with disease progression, showing the most dramatic perturbations in patients with full-blown AIDS associated with pulmonary infections (especially Pneumocystis carinii pneumonia) and lower peripheral CD4 lymphocyte counts. In contrast, patients with AIDS-related complex or AIDS without histological or cultural evidence of pulmonary involvement showed, respectively, only minimal or medium antigenic decreases. However, only a minor proportion (16%, 20%, 20%, 25%, and 25% respectively) of human immunodeficiency virus infected patients (mostly with AIDS) had a significant reduction of the levels of CD4, CD14, CD45R, CD11b, and CD16 antigens in the alveolar macrophages. Since macrophages play a central role in the pathogenesis of AIDS, it may be postulated that the loss of various phenotypic markers on alveolar mononuclear phagocytes (some of them known for their important immunoregulatory actions) could have an important part in the pathogenesis of human immunodeficiency virus induced immunosuppression, and thereby condition the abnormal susceptibility to pulmonary diseases typical of human immunodeficiency virus-infected patients.
authors.affiliation: Institute of Hematology, University of Ferrara, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Lanza
authors.forename: L
authors.initials: L
authors.lastname: Ferrari
authors.forename: L
authors.initials: L
authors.lastname: Sighinolfi
authors.forename: F
authors.initials: F
authors.lastname: Ghinelli
authors.forename: A
authors.initials: A
authors.lastname: Latorraca
authors.forename: S
authors.initials: S
authors.lastname: Moretti
authors.forename: L
authors.initials: L
authors.lastname: Trevisani
authors.forename: A
authors.initials: A
authors.lastname: Potena
authors.forename: F
authors.initials: F
authors.lastname: Malavasi
authors.forename: G
authors.initials: G
authors.lastname: Castoldi
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000276:immunology*; D000328:Adult; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D000939:Epitopes / Q000097:blood*; D005434:Flow Cytometry; D006801:Humans; D016130:Immunophenotyping; D008171:Lung Diseases / Q000150:complications / Q000276:immunology*; D016676:Macrophages, Alveolar / Q000276:immunology*; D010586:Phagocytes / Q000276:immunology*
chemical_list: D000939:Epitopes